Recurrence of insulin resistant metabolic syndrome following liver transplantation

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 1, 2003, Pages 99-102

  Angelico, Francesco ^a,c   Del Ben, Maria ^a   Francioso, Simona ^a   Hurtova, Monika ^a   Battista, Serena ^b   Palmieri, Gian Piero ^b   Tisone, Giuseppe ^b   Angelico, Mario ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c NONE   (Italy)

Author keywords

Cardiovascular risk factors; Cryptogenic cirrhosis; Liver transplantation; Metabolic syndrome; Non alcoholic steatohepatitis

Indexed keywords

CYCLOSPORIN A;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HEPATOMEGALY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; STEATOSIS;

FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; MIDDLE AGED; RECURRENCE;

EID: 0037249242     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200301000-00018     Document Type: Article

References (11)

1. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 1994; 37:948-952.
2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
3. Comert B, Mas MR, Erdem H, Dinc A, Saglamkaya U, Cigerim M, et al. Insulin resistance in non-alcoholic steatohepatitis. Digest Liver Dis 2001; 33:353-358.
4. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
5. Ong J, Younossi ZM, Reddy V, Lyn Price L, Gramlich T, Mayes J, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transplant 2001; 7:797-801.
6. Caldwell SH, Oelsner DH, lezzoni JC, Hespenheiden EE, Battle EH, Driscoll CJ. Cryptogenetic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29:664-669.
7. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
8. Kim WR, Poterucha JJ, Porayko K, Steers JL, Wiesner RH. Recurrence of non-alcoholic steatohepatitis following liver transplantation. Transplantation 1996; 62:1802-1805.
9. Carson K, Washington MK, Treem WR, Clavien PA, Hunt CM. Recurrence of non-alcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg 1997; 3:174-176.
10. Molloy RM, Komorowski R, Varma RR. Recurrent non-alcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 1997; 3:177-178.
11. Canzanello VJ, Schwartz L, Taler SJ, Textos SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporin A and tacrolimus (FK506). Liver Transpl Surg 1997; 3:1-9.